ICCC
#3978
ImmuCell Corporation - Common Stock
9.9 4 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.80%
Monthly Change
-9.72%
6 month change
+48.58%
Year Change
+58.03%
Previous Close
10.0 2
Open
9.9 4
Low
9.9 4
High
9.9 4
Volume
2
Financials
- Market Capitalization 90.28 M
- Employee 73
- Founded 1982
- CEO Michael F Brigham
- Website www.immucell.com
- Headquarter Delaware, United States
- FIGI BBG000BLQ5Q2
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-51.25
Price to sales ratio
2.01
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3972 |  ATRA Atara Biotherapeutics, Inc. - Common Stock | 9.20 USD | -0.54% | -3.87% | +12.47% | -37.63% | 92.35 M USD | ||
| 3973 |  PYPD PolyPid Ltd. - Ordinary Shares | 5.07 USD | -0.98% | -0.98% | +22.76% | +49.56% | 92.29 M USD | ||
| 3987 |  ALDX Aldeyra Therapeutics, Inc. - Common Stock | 1.49 USD | -3.25% | -2.61% | -8.59% | -74.40% | 89.89 M USD | ||
| 3994 |  RLYB Rallybio Corporation - Common Stock | 16.81 USD | +0.30% | +1.63% | +5.66% | +3132.69% | 89.27 M USD |
Frequently asked questions about Immucell Corp
What is the Immucell Corp stock price today?
The current price of Immucell Corp (ICCC) is 9.94. Over the past 24 hours, the stock has changed by -0.80%. Follow the ICCC chart for real-time price dynamics.
What is the stock ticker of Immucell Corp?
Immucell Corp trades under the ticker ICCC. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Immucell Corp stock going up?
ICCC has changed by -1.19% over the last week, -9.72% over the last month, and +58.03% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Immucell Corp?
Immucell Corp currently has a market capitalization of 90.28 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Immucell Corp earnings last quarter?
Last quarter, Immucell Corp reported earnings of 0.2 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Immucell Corp revenue for the last quarter?
Immucell Corp reported quarterly revenue of 7.19 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Immucell Corp net income for the last quarter?
Immucell Corp reported net income of 1.83 M for the last quarter. The previous quarter showed 1.94 M, which means net income changed by -5.51%.
How many employees does Immucell Corp have?
As of the latest available data, Immucell Corp has 73 employees. Workforce size can provide additional context about the company's scale and operations.
What is Immucell Corp EBITDA?
Immucell Corp EBITDA is 2.41 M, and its EBITDA margin is 33.48%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Immucell Corp stock?
You can buy Immucell Corp (ICCC) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Immucell Corp stock?
Investing in Immucell Corp requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ICCC chart and related analysis on metatrader.com as part of your research.